LONG MINI-FUTURE - ROCHE GS Share Price

Certificat

MROGG

CH0190479078

Real-time Bid/Ask 09:36:09 10/05/2024 BST
1.34 CHF / 1.35 CHF +6.75% Intraday chart for LONG MINI-FUTURE - ROCHE GS
1 month+2.44%
3 months-3.08%
Date Price Change Volume
08/05/24 1.26 +0.80% 0
07/05/24 1.25 +4.17% 0
06/05/24 1.2 +2.56% 0
03/05/24 1.17 +5.41% 0

Delayed Quote Swiss Exchange

Last update May 08, 2024 at 04:20 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
MROGG
ISINCH0190479078
Date issued 14/08/2012
Strike 158.9 CHF
Maturity Unlimited
Parity 50 : 1
Emission price 0.21 CHF
Emission volume N/A
Settlement règlement en espèces
Currency CHF

Technical Indicators

Highest since issue 4.9 CHF
Lowest since issue- CHF
Spread 0.01 CHF
Spread %0.74%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
222.3 CHF
Average target price
279.4 CHF
Spread / Average Target
+25.68%
Consensus
  1. Stock Market
  2. Certificates
  3. MROGG Certificat